Paradigm Biopharmaceuticals Limited
PBIGF
Other OTC0.12
USD
-0.03
- -
Total Valuation
Paradigm Biopharmaceuticals Limited carries a market capitalization of 52.01M, placing it among publicly traded companies globally.
| Market Cap | 52.01M |
| Enterprise Value | N/A |
Stock Price Statistics
Paradigm Biopharmaceuticals Limited's stock has declined approximately -47.50656% over the past 52 weeks. The 50-day moving average sits at 0.14, while the 200-day moving average is 0.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -47.50656% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.20 |
| Average Volume (20 Days) | N/A |
Stock Splits
Paradigm Biopharmaceuticals Limited's most recent stock split took place on November 1, 2023 with a 250:257 split ratio.
| Last Split Date | 11/1/2023 |
| Split Ratio | 250:257 |